David-Alexandre Gros

Dr. David-Alexandre C.
Gros is a Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. He is on the Board of Directors at Eledon Pharmaceuticals, Inc. Dr. Gros was previously employed as a Chairman & Chief Executive Officer by Sabeton SA, a Chairman & Chief Executive Officer by Imbria Pharmaceuticals, Inc., a President, Chief Operating & Financial Officer by Neurocrine Biosciences, Inc., a Chief Financial Officer by Alnylam Pharmaceuticals, Inc., a Member-Supervisory Board by Sabeton SA, a Chief Strategy Officer & Executive Vice President by Sanofi, a Chief Strategy Officer by Sanofi, a Principal by Centerview Partners LLC, and an Associate Principal by McKinsey & Co., Inc. He also served on the board at Eliem Therapeutics, Inc. He received his undergraduate degree from Dartmouth College, an MBA from Harvard Business School and a doctorate degree from The Johns Hopkins University School of Medicine.